insights_auto
Outlook: 61.5% bullish·0.0% bearish
Go to analysischevron_right
NOVN:SWX
Novartis AG
CHF 131.50
arrow_downward
-0.02%(-0.020) 1D
Nov 3, 5:30:38 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 133.00
High
CHF 133.12
Low
CHF 131.22
Mkt. cap
265.44B
Avg. vol.
3.32M
Volume
2.85M
Dividend
2.81%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
30.49
52-wk high
CHF 135.06
52-wk low
CHF 99.15
EPS
CHF 4.31
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 133.00
High
CHF 133.12
Low
CHF 131.22
Mkt. cap
265.44B
Avg. vol.
3.32M
Volume
2.85M
Dividend
2.81%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
30.49
52-wk high
CHF 135.06
52-wk low
CHF 99.15
EPS
CHF 4.31
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
BigGo Finance
·
10 hours ago
Alteogen Tops 100 Billion Won in Quarterly Revenue for First Time on Keytruda SC, Novartis Deals
Yahoo Finance
·
19 hours ago
BioArctic collaborator Novartis terminates agreement
www.marketscreener.com
·
1 day ago
Switzerland's Blue-chip Index Closes Little Changed; Novartis, PolyPeptide Group Shares Down
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com